EFL

Cohort Year: 2024-2025

Tracks: Life Sciences

VISIT WEBSITE

Cellinfinity Bio

Cellinfinity Bio is developing novel viral vectors that genetically reprogram T-cells in situ (within patients) to generate multigene, enhanced CAR-T cells against solid tumors and autoimmune diseases.